Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
- PMID: 19181509
- PMCID: PMC7172557
- DOI: 10.1016/j.rmed.2008.12.019
Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
Abstract
Background: Acute exacerbation (AE) is currently established as a distinct condition with acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently, several studies have reported that AE also occurred in interstitial pneumonias other than IPF, such as collagen vascular disease-associated interstitial pneumonia (CVD-IP). However, the incidence of AE in CVD-IP and its clinical characteristics remain to be fully determined. This study was conducted to elucidate cumulative incidence of AE in CVD-IP and its clinical features.
Methods: We reviewed 83 biopsy-proven CVD-IP patients, estimated cumulative incidence of AE, and examined its clinical characteristics.
Results: Among 83 CVD-IP patients, six patients with a mean age of 65.7 years developed AE (overall incidence, 7.2%; 1-year incidence, 1.25%). Underlying CVDs included rheumatoid arthritis (RA) (n=5; overall incidence, 20.0%) and primary Sjögren syndrome (n=1; overall incidence, 5.9%). Patients with AE showed acute respiratory deterioration with severe hypoxemia (mean PaO(2)/FiO(2) ratio, 131). Radiologically, ground-glass opacity was superimposed on the underlying reticular abnormalities. Preexisting histological patterns included three usual interstitial pneumonia (UIP) and two non-specific interstitial pneumonia (NSIP). Five (83.3%) of six patients died of respiratory failure despite intensive therapy. Univariate Cox's proportional hazards analysis showed that age and RA diagnosis were significantly associated with AE. Multivariate Cox's proportional hazards analysis indicated that age was an independent significant factor predicting AE.
Conclusions: These data suggest that AE can occur in CVD-IP, and this condition is closely similar to that of IPF with poor prognosis. AE is most common in RA, and associated with higher ages.
Figures




Similar articles
-
Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.Chest. 2007 Jul;132(1):214-20. doi: 10.1378/chest.07-0323. Epub 2007 Mar 30. Chest. 2007. PMID: 17400667
-
Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.Respiration. 2012;83(1):20-7. doi: 10.1159/000329893. Epub 2011 Sep 6. Respiration. 2012. PMID: 21912082
-
Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.Chron Respir Dis. 2019 Jan-Dec;16:1479972318809476. doi: 10.1177/1479972318809476. Epub 2018 Oct 31. Chron Respir Dis. 2019. PMID: 30380910 Free PMC article.
-
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758. Chron Respir Dis. 2011. PMID: 21339375 Review.
-
Acute exacerbation of interstitial lung disease after procedures.Respir Med. 2019 Apr;150:30-37. doi: 10.1016/j.rmed.2019.02.012. Epub 2019 Feb 12. Respir Med. 2019. PMID: 30961948 Review.
Cited by
-
Pulmonary manifestations of Sjögren's syndrome.Eur Respir Rev. 2016 Jun;25(140):110-23. doi: 10.1183/16000617.0011-2016. Eur Respir Rev. 2016. PMID: 27246587 Free PMC article. Review.
-
Interstitial lung disease on the acute take for the non-respiratory physician.Clin Med (Lond). 2021 Nov;21(6):e584-e590. doi: 10.7861/clinmed.2021-0694. Clin Med (Lond). 2021. PMID: 34862217 Free PMC article.
-
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease.Tuberc Respir Dis (Seoul). 2019 Oct;82(4):285-297. doi: 10.4046/trd.2019.0009. Epub 2019 May 31. Tuberc Respir Dis (Seoul). 2019. PMID: 31172701 Free PMC article. Review.
-
Exploring the role and mechanism of Astragalus membranaceus and radix paeoniae rubra in idiopathic pulmonary fibrosis through network pharmacology and experimental validation.Sci Rep. 2023 Sep 4;13(1):10110. doi: 10.1038/s41598-023-36944-1. Sci Rep. 2023. PMID: 37666859 Free PMC article.
-
Effectiveness of polymyxin B hemoperfusion in acute exacerbation of interstitial pneumonia: a retrospective analysis.Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(1):e2021012. doi: 10.36141/svdld.v38i1.9734. Epub 2021 Mar 31. Sarcoidosis Vasc Diffuse Lung Dis. 2021. PMID: 33867795 Free PMC article.
References
-
- Kondoh Y., Taniguchi H., Kawabata Y., Yokoi T., Suzuki K., Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest. 1993;103:1808–1812. - PubMed
-
- Ambrosini V., Cancellieri A., Chilosi M. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J. 2003;22:821–826. - PubMed
-
- Martinez F.J., Safrin S., Weycker D. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005;142:963–967. - PubMed
-
- Kim D.S., Park J.H., Park B.K., Lee J.S., Nicholson A.G., Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006;27:143–150. - PubMed
-
- Hyzy R., Huang S., Myers J., Flaherty K., Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652–1658. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical